home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Webinar on Managing Product Corrections & Removals in Accordance with 21 CFR, Part 806

  October 01, 2015  

Compliance Trainings, Mississauga

Description :

Compliance with 21 CFR, Part 806 (Medical Devices; Reports of Corrections and Removals) is not optional for device manufacturers wanting to enter medical devices into commerce in the United States. Compliance is driven, in part, by recall classification (three device classes in the U.S.). The Recall Classification (1, 2, or 3), premised on risk, will drive the amount of oversight and reporting required by FDA. A medical device recall is always a challenging event for device manufacturers because it is an activity that hopefully is not called upon much. However, having a well-documented approach to managing recalls and employees that are appropriately trained are key in executing recalls successfully.

If your organization is struggling with understanding the salient requirements associated with 21 CFR, Part 806, this webinar is for you. This webinar will help your organization better understand the FDA’s expectations for implementing an effective recall program, including tools needed to successfully execute product recalls including:

(a) creation of a recall notification packet

(b) product recovery and quarantine

(c) reporting required by FDA

(d) product rework and/or destruction

(e) effectiveness checks

(f) closing the recall.

For establishments already having a compliant approach for corrections and removals, this webinar will help your organization streamline their approach to managing recalls effectively.


Areas Covered in the Session :

Reviewing and understanding the requirements associated with 21 CFR, Part 806 compliance

Regulatory and statutory requirements

Recall classification

The recall process

Notifying FDA

Creating the recall notification packet

Notifying customers

Product recovery and quarantine

Periodic reporting requirements

Effectiveness checks

Third-party providers

Product disposition (rework and/or destruction)

Closing the recall

Who Will Benefit:

Quality Professionals

Regulatory Professionals

Risk Management Specialists

Complaint Managers and Specialists

Compliance Officers

Customer Service Professionals

Sales/Marketing Professionals


Senior and mid-level Management

Organized by: Compliance Trainings
Invited Speakers:

Dr. Christopher Joseph Devine is the president and founder of Devine Guidance International, Inc., (DGII) a consulting firm providing regulatory and quality compliance support for the medical device industry. Prior to launching DGII, Dr. D spent 14-years with Boston Scientific Corporation working in a variety of quality and regulatory management roles. Additionally, Dr. Devine is the author of Devine Guidance, a weekly blog focusing on quality and regulatory compliance issues facing the medical device industry; and published by the Medical Device Summit, an e-magazine.

Deadline for Abstracts: 2015-10-15

For more information about this event please visit





To register this webinar 

E-mail: suzzane.d@compliancetrainings.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.